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The development and evaluation of an audit tool for measuring reporting accuracy of radiographers compared with radiologists for intra-luminal pathology detected at Computed Tomography Colonography (CTC)
Abstract
Objective: To design and test an audit tool to measure the reporting accuracy of radiographers using radiologist reports as the gold standard. Design: A database was designed to capture radiographer read and radiologist report data. The radiographer 1st read of intraluminal pathology was given a score (PDS score) by the reporting radiologist based on the pathology present, the discrepancy between the 1st read and the final report and the significance of that discrepancy on the clinical management of the patient. 30 randomly selected cases (n=1800) were retrospectively compared and assessed for accuracy using the PDS score by 3 independent practitioners. Inter rater reliability was assessed using percentage agreement and kappa scores. Results: There was 100% agreement between participants for all significant pathologies. Inter rater agreement was 80-93% for normal studies and insignificant pathologies. Conclusion: Results indicate that the tool provides a practical, easy to use and reliable method to record, monitor and evaluate a first read of the colon by radiographers.
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Background
Bowel cancer is the third most common cancer in both men and women with 40,695 new cases diagnosed in the UK in 2010. Incidence is strongly related to age with 73% of cancers presenting in people aged 65 and over, and the highest rates found in those aged 85 and over[1]. Because the incidence of mortality from bowel cancer is strongly linked to tumour size and progression with “larger polyps having a greater likelihood of being or becoming an adenocarcinoma” [2]  it makes sense to detect bowel cancer early. Research suggests more than 90% of bowel cancer patients will survive the disease for more than five years if diagnosed at the earliest stage[1, 3] .Recognition of this has resulted in a national screening programme for bowel cancer which started in 2006 and is now available throughout the UK. The bowel screening programme is predicted to save over 2,000 lives each year by 2025 by identifying not only adenocarcinomas which account for 95% of all colorectal tumours but by detecting polyps, a non-malignant precursor to the colonic tumour [2]. 
The current methods of imaging the bowel for patients with symptoms suggestive of a colorectal cancer are optical colonoscopy (OC), barium enema (BE) and Computed Tomography Colonography (CTC). The SIGGAR Trial has published two papers looking at CTC versus BE and optical colonoscopy versus barium enema. The trial concluded that “CTC detects significantly more colorectal cancers or large polyps than does BE, and has a lower miss rate for colorectal cancer. CTC is a less burdensome procedure than BE, particularly for older patients” [4].When CTC was compared to optical colonoscopy the trial concluded that “for most patients CTC provided a similarly sensitive, less invasive alternative to optical colonoscopy” [5].
CTC or virtual colonoscopy is a relatively new method of examining the large bowel. With suitable bowel preparation of the patient, insufflation of the bowel lumen with CO2 and 3D reconstruction of the resulting images the colon can be demonstrated to a standard comparable to OC [5].In addition it has the advantage of still producing diagnostic results even when good bowel preparation has not been achieved or where full cathartic bowel prep would be inappropriate [5]. NICE guidance recommends the use of CTC over BE for imaging the colon “wherever resources and skill mix permit” [6]. 
Any decisions on imaging must be made with consideration to the need for purgative bowel preparation for OC and BE. Some patients are unsuitable for cathartic bowel prep due to limiting co-morbidities or poor mobility. The NPSA alert on “Reducing risk of harm from oral bowel cleansing solutions” published in 2009 [7] laid down clear guidelines on the use of bowel cleansing which have impacted on the number of patients offered CTC with a reduced bowel preparation as a safer option to OC or BE.
These factors, combined with a move towards extending the upper age limit for bowel screening, an ageing population and an expectation from service users that the “best test” will be offered means the demand for CTC is set to increase at a rapid rate. In order to manage this pressure on resources whilst providing a viable, efficient service capable of challenging other service providers (AQP) in the future, radiographer engagement in image reporting will be essential [8]. It is therefore necessary to audit the performance of radiographers in the quality and accuracy of their reports.
With Gastrointestinal (GI) radiographers transferring their skills from BE to CTC there is a need for them to develop comparable competencies in evaluating the bowel for this modality. A recent systematic review of radiographer reporting of this examination acknowledged that with sufficient training and experience radiographers could offer a valuable contribution in evaluating the lumen of the bowel [9], ADDIN EN.CITE [10].
A recent study looking at the diagnostic performance of CTC reported by radiologists and radiographers [10] concluded that the reporting accuracy of trained radiographers was comparable to that of experienced radiologists. When the demand for CTC is looked at, alongside the requirement to meet stringent time targets both in delivering and reporting on examinations provided for the NHS, it is clear that inventive ways of supporting the reporting radiologist need to be considered [11] and it would seem appropriate to look to radiographers for the solution.  

Aims of the study 
To develop an audit tool to assess radiographer reporting accuracy when compared with the gold standard radiologist report for CTC examinations in a clinical setting.
To validate the audit tool by repeating the report scoring process with a single dataset and multiple users
Study design
Descriptors were set to group reports by pathology with conservative parameters for each group. These were established using accepted published data on recommendations for the reporting of findings at CTC [12],[13]. The CT Colonography Reporting and Data System (C-RADS) uses a scale of C0-C4 to categorise Ct colonography findings [14].




C1	Polyps ≤ 6mm	Continue routine surveillance
C2	Intermediate polyp 7mm-9mm	Surveillance or colonoscopy recommended
C3	Polyps ≥ 10mm	Follow up colonoscopy recommended
C4	Colonic mass or malignancy	Surgical consultation recommended

This audit tool assigned a pathology or “P score” using very similar parameters but was more cautious by establishing a cut off of ≤ 4 mm for polyps in  the P2 group (≈ C1). This was done because at the time of the study the local policy was for radiologists to report on all polyps, however small. As a result all diminutive polyps seen at CTC were described in the final report and it was important that the radiographer read reflected this. 
Table 2 - P Score descriptors
	Score	Pathology
P0	Not scored, inadequate study
P1	No intra-luminal pathology reported
P2	Diminutive polyp ≤ 4mm, diverticulae
P3	Small polyp  5mm – 9mm / diverticular disease to include wall thickening and stricturing
P4	Polyp ≥ 10mm, carcinoma, complicated diverticular disease (collection, fistula, abscess)

Using these P scores the radiographer read was assigned a final score which incorporated the P score, the level of correlation between the two reports and the clinical significance of any discrepancy demonstrated. This is the “pathology discrepancy and significance score” (PDS score) and is recorded by the radiologist at the time of reporting.
Table 3 – PDS score descriptors
Score	Description
PDS0		Not scored – inadequate study / missing data
PDS1	Report agreement  (P1-P4 reports)
PDS2	Discrepancy with P2 reports (insignificant discrepancy)
PDS3	Discrepancy with P3 report
PDS4	Discrepancy with P4 report

It is this score which is used to determine radiographer accuracy.
Method









A database was set up using Access 2010 (Microsoft Corporation) to capture the following – 
Table 4 – database information 
Patient ID	Patient identifier, number unique to each study.
Radiographer ID	Initials of the 1st read radiographer.
Radiologist ID	Initials of the reporting radiologist.
Study date	Date of examination.
Radiographer report	Radiographer findings to include presence and severity of diverticular disease and the presence, size and location of any polyps or malignancy. Description of location to include anatomical area and CT slice number for both prone and supine scans.
PDS score	The PDS score represents a measure given to describe report discrepancies which considered both the difference between the two reports and the clinical significance of that discrepancy.
Radiologist comments	Descriptive comments to support the PDS score. These may also include constructive feedback to the radiographer as part of the ongoing training and development of reporting skills.
Further comments	For follow up information on further examinations such as endoscopy or pathology reports

From this database of 1815 cases 30 were randomly selected for retrospective audit using the tool described. The purpose of this was to determine whether the audit tool produced consistent and replicable results, irrespective of who undertook the scoring. The study was approved by the Trust Clinical Audit Team. 
The radiographer entered the patient demographics and their findings as described above. The radiologist checked the radiographer read with their own findings; made comment on any pathology missed and scored the relevance of the discrepancy (PDS score). They also added their identity to the database to enable the radiographer to identify their supervisor if required. The final report was issued with consideration given to the radiographer findings thus providing a double read of the bowel and improving the sensitivity of the test [15].
For the purpose of the audit tool validation an additional two radiographers were also asked to undertake the scoring process. Both were experienced GI radiographers, one a trainee “1st reader” and the other with an established role in evaluating intra-luminal pathology at CTC. They worked independently and without prior knowledge of the radiologist score.
The aim was to determine whether the PDS score could be reliably replicated by other users and therefore suitable as an audit tool for a much bigger research project looking at the entire database. 30 studies selected at random from the database were scored independently by the two radiographers and a radiologist to produce three datasets for evaluation.
Agreement was tested using percentage agreement and Kappa scores in recognition of the need to consider both to interpret reliability when there is high agreement between raters and little variation in scores across the categories[16, 17] 
Results
The sample reports selected for audit contained adequate pathology to test the audit tool with pathology reported on 25 of the 30 studies. 
Table 5 - Pathology Distribution
P Score	Distribution	Description
P1	5	Normal - 5




The results demonstrated agreement between tool users ranged from 80 – 93% for normal studies and insignificant discrepancies. 
Insert table 6
Table 6 - Summary of statistical analysis
	Number of valid cases	% agreement	Kappa score
Radiologist  v experienced radiographerRadiologist v trainee radiographerExperienced radiographer v trainee radiographer	303030	938087	**.444
			

*Kappa scores were not calculable or poor because of low or no variance between responses[18].
A PDS score of 0 was not recorded by any participants indicating that all studies included were diagnostic and the radiographer 1st read and final radiology report were documented on the database.PDS scores of 3 and 4 were not recorded by any participants indicating 100% agreement between participants for any significant (P3 and P4) pathologies.
Discussion of results
This study involved a relatively small dataset from the total database of over 1800 cases; a larger dataset may have given more robust measures of validity and reliability.  However, the current number was considered to have sufficient degrees of freedom to provide a reasonably robust result.  
As there were no PDS scores of 3 or 4 and all the radiologists’ scores were 1 there was insufficient variability in the results to enable a kappa score to be obtained. This will frequently occur in datasets such as these where there is good agreement.[18].
If scores for PDS1 and PDS2 (full agreement and insignificant discrepancies) are combined, inter-rater agreement becomes 100% for all participants using the audit tool to assess reader / reporter agreement. Because current policy is for all intra-colonic pathology to be mentioned in the radiologist report it was felt appropriate for the radiographer to comment on all polyps, however small, and to detail size, position and degree of certainty in diagnosis. The decision on whether to include diminutive polyps in the final report lay with the radiologist but the need to include these findings increased the likelihood of reader or reporter error or discrepancy as sensitivity and specificity for polyp detection at CTC reduces with reduced polyp size [5]. 
Making the effort to detect and describe diminutive polyps did however give the trainee the opportunity to develop advanced skills in pattern recognition and use of the reporting software in the clinical setting where, whilst all patients were symptomatic or had a positive FoB result through the BCSP, pathology was likely to be less frequent than in a more “customised” training environment where positive cases are pre-selected for interpretation. 
The study uses a polyp size of 4mm as the cut off between diminutive and small polyps. This decision recognises the discrepancies around accurate measurement of polyps with CT under sizing when compared to endoscopy, and endoscopy over sizing when compared with pathology specimens [2]..It is acknowledged that this is not in line with the findings of many studies [19],[20] where a more conservative approach to intervention is advocated but setting the standards described and ensuring rigorous assessment of training through audit encourages recognition, reporting and measuring of small lesions by the radiographers and supports opinion from other studies advising surveillance and / or polypectomy for small and diminutive polyps [20], ADDIN EN.CITE [21]. These studies acknowledge the lack of data as polyps, once detected, are usually removed [20] and agree that establishing a cut off size for polypectomy is difficult which in turn makes the decision by the radiologist to report on small and diminutive polyps equally controversial.
Review of scoring by the different participants, even with the small numbers used, suggests that the more experienced the reader the less likely they are to score an insignificant discrepancy and the more confident they are in calling subtle differences in pathology descriptions a match. If it had been possible to have all studies matched independently by 3 radiologists the tool may have demonstrated a higher degree of reliability. It should be noted that, in the clinical setting, a radiologist is responsible for producing all PDS scores.
In clinical use as an audit tool it would be necessary to set standards by which to measure radiographer performance based on the PDS scores achieved. This has not been described in this paper as its purpose was solely to describe and validate the tool. 
Finally, it is also important to emphasise that the audit tool does not recognise the accuracy of either report or identify when the radiologist report is changed in response to the opinion of the radiographer. Neither would it identify a significant missed pathology if the lesion was missed by both radiographer and radiologist. The team using this tool in clinical practice is however, confident that double reporting of CTC images reduces the likelihood of such an event occurring[15]. 
Conclusion 
The results indicate that the audit tool provides a practical, easy to use and reliable method to record, monitor and evaluate a first read of the colon by radiographers. It provides an effective method of recording data which can be accessed to support radiologist reporting whilst providing radiographer training, support and audit. Over time it can be used to monitor effectiveness of training models and provide data on the individual performance of radiographers providing a 1st read of intraluminal pathology as part of a radiology report.
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